Abstract:Objective:To study the efficacy and indications of percutaneous radiofrequency ablation combined with interstitial chemotherapy for primary liver cancer.
Methods :The clinical data of 52 cases with primary liver cancer treated by percutaneous radiofrequency combined with interstitial chemotherapy were analysed retrospectively.
Results:Symptoms were significantly ameliorated in 85% of the patients. After the treatment, AFP level declined in 58% of the patients. The postoperative 1-,2-,3-,4-year surrival rate were 92%,78%,56%,43%, respectively.
Conclusions:Percutaneous radiofrequency ablation combined with interstitial chemotherapy is a new safe, reliable and effective method for management of liver cancer.